483
Concord Biotech LimitedConcord Biotech Limited – FDA 483, May 2, 2025
Record Details
An FDA inspection of Concord Biotech Limited in Dholka Ahmedabad, India, revealed significant deficiencies in manufacturing practices for Active Pharmaceutical Ingredients (API). Observations included inadequate equipment cleaning, insufficient laboratory controls for microbiological testing verification, and poor data integrity controls for computerized systems. Additionally, the firm failed to properly monitor and control water quality used in API manufacturing steps.
View Company Profile
ID · ca5090cf-c290-4f3a-a498-cd2fd7f95cba
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.